In this study, researchers aimed to identify endometrial cancer patient preferences and gather insights on how these preferences might inform treatment decisions.

A phase 2 study suggests that immunotherapy plus radiation could spare some patients with advanced endometrial cancer from chemotherapy.

The risks and benefits of hormone replacement therapy use for menopausal symptoms in breast cancer survivors are examined in light of recent research.

Trastuzumab pamirtecan, a HER2-targeted antibody-drug conjugate, achieved ‘exceptional’ antitumor responses in patients with recurrent endometrial cancer, especially those with HER2 IHC 3+ tumors.

Data from the SISTER study show that 1:1 peer support significantly increases the odds that Black women with endometrial cancer will complete treatment, according to research pres ...

Two symptoms sit at the top of every gynecologic oncologist’s list when they talk about catching cancer before it becomes ...

I tried the $950 blood test Silicon Valley thinks can revolutionize cancer screening. The science—and my results—tell a ...

Advancing access and early action in women’s cancer care Women’s cancers—such as breast, cervical, and endometrial ...

Current tests for endometrial cancer often rely on procedures like transvaginal ultrasound and tissue biopsy to evaluate the uterine lining, methods that some women find stressfully uncomfortable. The ...

An Austin woman survived a diagnosis she never saw coming. Now she's spreading the word about endometrial cancer so other lives can be saved too.

When David Lyon saw blood in his stool, he didn't think much of it. He was a fit 26-year-old who worked in a sheet metal shop. The spots were inconsistent, and he thought he might have just sustained ...